Astonea Labpo IPO open today: Here’s what you need to know before subscribing

The initial offering of public (IPO) to GOODang usa ka kompanya nga nag-apil sa paghimo sa mga produksay sa Pharmaceutical ug kosmetiko, maablihan alang sa suskrisyon sa Mayo 27, ang kompanya nagtumong sa pag-ambit sa Rs 39.67 crore sa usa ka bag-ong bahin sa 27.90 nga mga bahin sa 27.90 nga mga bahin sa 27.90 nga mga bahin sa 27.90 nga mga bahin sa 27.90 nga mga bahin sa 27.90 nga mga bahin sa 27.90 lakh in parts of 27.90 shares of sharing 27.90 lakh. It is listed on the BSE SME platform, with a tentative date on June 3.

A Reats in Corporate is the Lead Running manager of the book, and Kfin Technologies the registrant of the issue.

The Astonea Labpo Price Band

Price band for IPO is set to Rs 128 to Rs 135 per share. Investors together can apply for a minimum of 1,000 portions, which require an investment in Rs 1,35,000 at high band prices. Long-net-net–net individuals (HNIs) can bid for a minimum two-lot (2,000 parts), which require Rs 2,70,000.

Part of the company

The constructed in 2017, the Labs of Astonea were involved in the contract of a wide pharmaceutical and cosmetic products. Its sacrifices include antibiotics, anti-cold medications, diabetes care, heart medicines, as well as nursing products such as gels, serums, creams, and more.

The company also published its own brands – “Glow Up” (Skincare) and “Regero” (Pharma). It plans to launch another brand called “Avicel” and exported products to countries such as Iraq and Yemen.

Using IPO funds

The company used IPO to continue for Bolivia registration costs, buying machines for fragrance promotion, buying capital and software requirements

Financial Snapshot

Astonea Labs posted a profit at Rs 4.10 crore in nine months ended December 2024 in a revenue of Rs 69.69 crore. The company shows a strong growth for many years with return to equity (Roe) 37.86% and Patar Margin at 4.75%.

(Matan -re: Recommendations, suggestions, views and opinions given to experts themselves. This does not represent views of economic times)